Cargando…
Targeting SAM-I Riboswitch Using Antisense Oligonucleotide Technology for Inhibiting the Growth of Staphylococcus aureus and Listeria monocytogenes
With the discovery of antibiotics, a productive period of antibacterial drug innovation and application in healthcare systems and agriculture resulted in saving millions of lives. Unfortunately, the misusage of antibiotics led to the emergence of many resistant pathogenic strains. Some riboswitches...
Autores principales: | Traykovska, Martina, Penchovsky, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686682/ https://www.ncbi.nlm.nih.gov/pubmed/36421306 http://dx.doi.org/10.3390/antibiotics11111662 |
Ejemplares similares
-
Targeting FMN, TPP, SAM-I, and glmS Riboswitches with Chimeric Antisense Oligonucleotides for Completely Rational Antibacterial Drug Development
por: Pavlova, Nikolet, et al.
Publicado: (2023) -
Tertiary contacts control switching of the SAM-I riboswitch
por: Hennelly, Scott P., et al.
Publicado: (2011) -
Exploring the energy landscape of a SAM-I riboswitch
por: Manz, Christoph, et al.
Publicado: (2021) -
The structure of the SAM/SAH-binding riboswitch
por: Weickhmann, A Katharina, et al.
Publicado: (2019) -
Role of horizontally transferred copper resistance genes in Staphylococcus aureus and Listeria monocytogenes
por: Kaur, Inderpreet, et al.
Publicado: (2022)